Robotic surgery giant Intuitive Surgical (NSDQ:ISRG) said today it inked a joint venture deal with Shanghai Fosun Pharmaceutical (SHA:600196) to research, develop, manufacture and sell robotic-assisted catheter-based medical devices. Both companies will contribute $100 million to start the joint venture, which will initially focus on development of early diagnostics and cost-effective treatments for lung cancer, one […]
Shanghai Fosun Pharmaceutical
Spirometrix lands $17m Series C for breath-based diagnostic device
Spirometrix said yesterday that it raised $17.4 million in the 1st tranche of its Series C round for the breath-based diagnostic device it’s developing for asthma patients. Shanghai Fosun Pharmaceutical (SHA:600196) led the round, joined by prior investors NGK Spark Plug, South Valley Angels, Iconical, Ohio Innovation Foundation and Carmen Innovation, Spirometrix said. The Fenom Pro device is designed […]
Astute Medical raises $20m, inks China distribution deal
Astute Medical said it raised $20 million from Shanghai Fosun Pharmaceutical (SHA:600196) and inked a distribution deal with the Chinese company for its NephroCheck kidney-injury test. The multi-year deal calls for Shanghai Fosun’s Long March Medicine Science subsidiary to distribute NephroCheck on the Astute140 meter in China. NephroCheck is marketed in the U.S. by Ortho-Clinical Diagnostics. “Our strategy is to deliver […]